NO20080824L - Oral prevensjon med trimegeston - Google Patents

Oral prevensjon med trimegeston

Info

Publication number
NO20080824L
NO20080824L NO20080824A NO20080824A NO20080824L NO 20080824 L NO20080824 L NO 20080824L NO 20080824 A NO20080824 A NO 20080824A NO 20080824 A NO20080824 A NO 20080824A NO 20080824 L NO20080824 L NO 20080824L
Authority
NO
Norway
Prior art keywords
trimegestone
birth control
oral birth
oral
successive days
Prior art date
Application number
NO20080824A
Other languages
English (en)
Inventor
Heinrich Kugelmann
Oliver Gloger
Maria Popova
Tamara Pfaff
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37575731&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20080824(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2006/007103 external-priority patent/WO2007009769A1/en
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of NO20080824L publication Critical patent/NO20080824L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Oppfinnelsen omhandler en fremgangsmåte for svangerskapsforebygging som omfatter administreringen av trimegeston i kombinasjon med etinyløstradiol til en kvinne i fruktbar alder i minst 21 suksessive dager, ved å begynne på dag 1 av menstruasjonssyklusen, hvori den daglige trimegestondose er mer enn 500 µg på minst én av de minst 21 suksessive dager.
NO20080824A 2005-07-20 2008-02-15 Oral prevensjon med trimegeston NO20080824L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005034498A DE102005034498A1 (de) 2005-07-20 2005-07-20 Orale Kontrazeption mit Trimegeston
US11/348,545 US20070021396A1 (en) 2005-07-20 2006-02-06 Oral contraception with trimegestone
PCT/EP2006/007103 WO2007009769A1 (en) 2005-07-20 2006-07-19 Oral contraception with trimegestone

Publications (1)

Publication Number Publication Date
NO20080824L true NO20080824L (no) 2008-04-18

Family

ID=37575731

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080824A NO20080824L (no) 2005-07-20 2008-02-15 Oral prevensjon med trimegeston

Country Status (13)

Country Link
US (3) US20070021396A1 (no)
JP (1) JP2009501747A (no)
CN (1) CN101267827A (no)
BR (1) BRPI0614672A2 (no)
DE (1) DE102005034498A1 (no)
EC (1) ECSP088123A (no)
IL (1) IL188751A0 (no)
MX (1) MX2008000844A (no)
NO (1) NO20080824L (no)
NZ (1) NZ565829A (no)
PE (1) PE20070208A1 (no)
RU (1) RU2008105834A (no)
ZA (1) ZA200800373B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004026671A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
EP2027855A1 (de) * 2007-08-24 2009-02-25 Bayer Schering Pharma AG Verwendung von Gestagenen in Kombination mit (6S)5-Methyltetrahydrofolat zur Therapie der Endometriose mit gleichzeitiger Verminderung von Therapie-Nebenwirkungen sowie der Verminderung des Risikos angeborener Fehlbildungen bei Eintritt einer Gravidität
DE102007047608A1 (de) * 2007-10-04 2009-04-09 Grünenthal GmbH 19-nor-Progesterone zur Kontrazeption
CA2813433C (en) 2010-10-27 2019-08-20 Dignity Health Trimegestone (tmg) for treatment of preterm birth
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9326997B2 (en) 2012-09-24 2016-05-03 Ahlam E. Elakkad Composition and method for treation Oligoovulation, Oligomenorrhea and Amenorrhea
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP6386711B2 (ja) * 2013-10-01 2018-09-05 任天堂株式会社 情報処理システム、サーバ装置、サーバプログラム及び情報処理方法
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
JP6759478B2 (ja) * 2019-02-13 2020-09-23 富士製薬工業株式会社 経口固形組成物、その製造方法、及びその製造方法によって得られた経口用錠剤

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430953A1 (fr) * 1978-07-13 1980-02-08 Roussel Uclaf Nouveaux derives 3,20-dioxo 4,9-diene 21-hydroxyle, leur procede de preparation et leur application comme medicaments
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
FR2749514B1 (fr) * 1996-06-11 1998-08-07 Hoechst Marion Roussel Systemes transdermiques renfermant 2 principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament
JP2000515888A (ja) * 1996-07-26 2000-11-28 アメリカン・ホーム・プロダクツ・コーポレイション 経口避妊薬
WO1998004265A1 (en) * 1996-07-26 1998-02-05 American Home Products Corporation Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen
WO1998004269A1 (en) * 1996-07-26 1998-02-05 American Home Products Corporation Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
US6451778B1 (en) * 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US6511970B1 (en) * 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6326392B1 (en) * 1997-11-06 2001-12-04 American Home Products Corporation Anti-estrogen plus progestin containing oral contraceptives
EP1071428A2 (en) * 1998-04-17 2001-01-31 Ortho-Mcneil Pharmaceutical, Inc. Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
US7297688B2 (en) * 2000-06-08 2007-11-20 Wyeth Starter kit for low dose oral contraceptives
CN101099734A (zh) * 2002-08-15 2008-01-09 惠氏公司 用于治疗体温调节机能障碍的5HT2a受体的激动作用
EP1462107B1 (en) * 2003-03-28 2008-09-24 Pantarhei Bioscience B.V. Method of female contraception and kit for use in such method
GB2402745B (en) * 2003-06-10 2005-08-24 Activeem Ltd Electromagnetic surveying for hydrocarbon reservoirs
DE102004026671A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption

Also Published As

Publication number Publication date
US20100279989A1 (en) 2010-11-04
IL188751A0 (en) 2008-12-29
US20070021396A1 (en) 2007-01-25
MX2008000844A (es) 2008-03-18
ECSP088123A (es) 2008-02-20
BRPI0614672A2 (pt) 2012-12-04
NZ565829A (en) 2012-01-12
CN101267827A (zh) 2008-09-17
RU2008105834A (ru) 2009-08-27
ZA200800373B (en) 2009-08-26
JP2009501747A (ja) 2009-01-22
US20120028936A1 (en) 2012-02-02
PE20070208A1 (es) 2007-05-06
DE102005034498A1 (de) 2007-01-25

Similar Documents

Publication Publication Date Title
NO20080824L (no) Oral prevensjon med trimegeston
MX2009004616A (es) Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente.
ES2558030T3 (es) Método anticonceptivo oral multifásico de ciclo prolongado
RU2009148278A (ru) Применение эстриола в низкой дозе
EA201200377A1 (ru) Способ пероральной контрацепции у женщин, способ управления нежелательными кровотечениями и предназначенная для применения в этих способах фармацевтическая упаковка
TW200626161A (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
NO20072518L (no) Kjonns stereoid forloper alene eller i kombinasjon med en selektiv ostrogen reseptor modulator og /eller med ostrogener og /eller en type 5 CGMP fosfodiesteraseinhibitor for a forebygge eller behandle vaginal torrhet og seksuell dysfunksjon hos postmenopausale kvinner.
AR054525A1 (es) Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo
MX363536B (es) Gel transdermico de progestina/estradiol.
NZ602698A (en) Parenteral pharmaceutical form which releases aromatase inhibitor and gestagens, for the treatment of endometriosis
NZ591627A (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
PL2131847T3 (pl) Lek zawierający przynajmniej jeden gestagen
AR049197A1 (es) Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona
IL154975A0 (en) Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
MX2009010320A (es) Regimen anticonceptivo oral.
NO20072704L (no) Orale faste doseformer som inneholder en lav ostradioldose
HRP20090256T1 (en) Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method
BRPI0511864A (pt) uso de uma combinação de etinilestradiol e acetato de clormadinona para a preparação de um medicamento
NO20072687L (no) Farmasoytisk prevensjonspreparat
BRPI0414945A (pt) regimes contraceptivos trifásicos estendidos
CY1112775T1 (el) Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος
AR056674A1 (es) Anticoncepcion oral con trimegestona
RS50849B (sr) Upotreba estradiolvalerata i dienogesta za oralno lečenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu
RU2009142513A (ru) Способ профилактики пролапса гениталий у женщин репродуктивного периода

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application